Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

As you age, maintaining a daily habit of walking can prevent cognitive decline, especially for those most at risk, a new ...

Families across Georgia are finding new hope in the fight against Alzheimer’s disease, thanks to promising treatments at ...

There’s good news for older Americans at high-risk of developing dementia: simple steps to stay mentally and physically ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

New research builds on evidence that diet, certain brain training exercises and physical activity can delay the decline of ...

Research has suggested that about 40% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors — alcohol abuse, smoking, diabetes, obesity, high ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer's disease, ...

(Reuters) -Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer ...

(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...